Gapping down
In reaction to disappointing earnings/guidance:
- QUAD -19.3%, ENPH -10.3%, CSII -9%, AJRD -8.7%, TUP -8.3%, LDL -7%, MOH -7%, ACCO -6.5%, CHRW -6.1%, DB -5.9%, CRTO -5.9%, EXAS -5.6%, NBR -5%, EXTR -4.9%, DAN -4.8%, YUM -4.7%, SAN -4.4%, CYH -4.1%, CCS -4%, SAIA -3.8%, FEYE -3.7%, RNR -3.6%, APTV -3.5%, SYK -3.3%, NYCB -3.2%, CS -2.4%, AX -2.3%, UNM -2.3%, BG -2.1%, MDLZ -1.6%, GNW -1.6%, VNOM -1.6%, TMHC -1.6%, MAS -1.5%, EIX -1.4% (also says filed Electric Safety Incident Repor related to the Saddle Ridge fire out of abundance of caution because SCE had an event on its system close in time to the start of the fire), LSCC -1.4%, IQV -1.4%, MSTR -1.2%, OKE -1.1%, CIM -1.1%
Other news:
- AMAG -22.7% (FDA AdCom in final voting question votes in favor of pursuing withdrawal of approval for Makena)
- CPRX -14% (announces top-line results from CMS-001)
- YMAB -9.3% (commences registered underwritten public offering of up to $125 million in shares of its common stock)
- SESN -7% (under pressure after modifying 2017 and 2018 common stock warrants to allow for future at-the-market programs)
- MOH -7% (discloses that Texas Health and Human Services Commission notifies that it intends to award contracts to Molina Healthcare of Texas, Inc. for the STAR+PLUS program in the Hidalgo and North East service areas)
- FBC -3.9% (commences public secondary offering of 6.1 mln shares of common stock by MP Thrift Investments L.P.)
- NWBI -2.4% (Northwest Bancshares to acquire MutualFirst Financial in all-stock transaction valued at approx. $346 mln)
- SEDG -1.5% (following ENPH results)
- NVS -1.5% (announces AVXS-101 intrathecal study update; FDA placed a partial hold on AVXS-101)
Analyst comments:
- GRUB -4.2% (downgraded to Neutral from Buy at Goldman, among others)
- AMCX -1.9% (downgraded to Neutral from Buy at BofA/Merrill)
- LEG -1.3% (downgraded to Hold from Buy at SunTrust)
- CR -1% (downgraded to Hold from Buy at Canaccord Genuity)
- MAN -0.9% (downgraded to Hold from Buy at Argus)